President Donald Trump has called his rollout of TrumpRx "the biggest thing ever to happen on drug prices" and claimed the achievement alone "should win us the President Donald Trump has called his rollout of TrumpRx "the biggest thing ever to happen on drug prices" and claimed the achievement alone "should win us the

TrumpRx launch backfires as observers call out Trump's fuzzy math and buried 'fine print'

3 min read

President Donald Trump has called his rollout of TrumpRx "the biggest thing ever to happen on drug prices" and claimed the achievement alone "should win us the midterms." But critics rolled their eyes Thursday night after the official launch, particularly taking issue with his math not quite adding up, and pointing to the "fine print" that undercuts his boasts.

The new government website connects patients with discounted medications and printable coupons, capping Trump's year-long pressure campaign against big pharmaceuticals using tariff threats and expedited FDA reviews. At the Eisenhower Executive Office Building demonstration, Trump's team, including controversial Department of Government Efficiency official Edward Coristine and TV personality-turned-head of the Centers for Medicare & Medicaid Services, Mehmet Oz, showed off how Novo Nordisk's Ozempic could drop from $1,000 to $350 monthly.

"You will see dramatic reductions in the cost of popular weight loss drugs known as GLP-1s. GLP-1s. Novo Nordisk will be slashing the price, as an example, of Ozempic from more than $1,000 to $199. And the price of Wegovy from more than $1,300 to $199. Nobody can even believe it. A 578% difference."

Trump's enthusiasm crashed into a brick wall with skeptics, as Democrats demand concrete proof of actual savings. Northwestern University health economist Craig Garthwaite called it "far from revolutionary," noting most Americans can't afford brand-name drugs without insurance anyway.

Social media observers called out the president over his fuzzy math.

Jeff Domingues, editor at S&P Global, shot back on X, "No, it’s an 84.7% decrease. I constantly keep http://Percentagecalculator.net occupying a browser tab as a copy editing resource."

EU citizen Roland Ley chided on X, "Math. Not Trump's strength, like so many other things aren't either."

Software sales professional Dan Gleason pointed to the "fine print" showing the discounted prices were a limited-time offer for the first two monthly refills of Ozempic for new patients. He noted the price increased to $349 and $499 for months three and four.

Erin Ryan, writer and host of the Crooked Media podcast "Hysteria," jabbed on X, "Can science invent an injection that makes lazy adults understand basic math."

The progressive Call to Activism social media account wrote on X, "TRUMP FAILS AT MATH Trump brags about drug prices, claiming: Ozempic will drop from $1,000 to $199… a 578% difference.' That’s false. That’s an 80% cut, not 578%. Even worse? The 'price cuts' are for first time patients for a LIMITED-TIME. A farce.

Author and former freelance journalist Tracy Solomon wrote on X, "Aside from Trump needing a calculator, he also forgot to mention this is an introductory price only. There should always be captions with facts and added information while he speaks."

Market Opportunity
OFFICIAL TRUMP Logo
OFFICIAL TRUMP Price(TRUMP)
$3.373
$3.373$3.373
-9.47%
USD
OFFICIAL TRUMP (TRUMP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Is Putnam Global Technology A (PGTAX) a strong mutual fund pick right now?

Is Putnam Global Technology A (PGTAX) a strong mutual fund pick right now?

The post Is Putnam Global Technology A (PGTAX) a strong mutual fund pick right now? appeared on BitcoinEthereumNews.com. On the lookout for a Sector – Tech fund? Starting with Putnam Global Technology A (PGTAX – Free Report) should not be a possibility at this time. PGTAX possesses a Zacks Mutual Fund Rank of 4 (Sell), which is based on various forecasting factors like size, cost, and past performance. Objective We note that PGTAX is a Sector – Tech option, and this area is loaded with many options. Found in a wide number of industries such as semiconductors, software, internet, and networking, tech companies are everywhere. Thus, Sector – Tech mutual funds that invest in technology let investors own a stake in a notoriously volatile sector, but with a much more diversified approach. History of fund/manager Putnam Funds is based in Canton, MA, and is the manager of PGTAX. The Putnam Global Technology A made its debut in January of 2009 and PGTAX has managed to accumulate roughly $650.01 million in assets, as of the most recently available information. The fund is currently managed by Di Yao who has been in charge of the fund since December of 2012. Performance Obviously, what investors are looking for in these funds is strong performance relative to their peers. PGTAX has a 5-year annualized total return of 14.46%, and is in the middle third among its category peers. But if you are looking for a shorter time frame, it is also worth looking at its 3-year annualized total return of 27.02%, which places it in the middle third during this time-frame. It is important to note that the product’s returns may not reflect all its expenses. Any fees not reflected would lower the returns. Total returns do not reflect the fund’s [%] sale charge. If sales charges were included, total returns would have been lower. When looking at a fund’s performance, it…
Share
BitcoinEthereumNews2025/09/18 04:05
“Vibes Should Match Substance”: Vitalik on Fake Ethereum Connections

“Vibes Should Match Substance”: Vitalik on Fake Ethereum Connections

Vitalik Buterin criticized L2s that use optimistic bridges without adding meaningful technical innovation. Ethereum’s base layer is scaling, reducing the need for
Share
LiveBitcoinNews2026/02/06 11:30
Why Bitcoin Crashed Below $69,000 — Causes & Outlook

Why Bitcoin Crashed Below $69,000 — Causes & Outlook

Cryptsy - Latest Cryptocurrency News and Predictions Cryptsy - Latest Cryptocurrency News and Predictions - Experts in Crypto Casinos Bitcoin crash explained:
Share
Cryptsy2026/02/06 11:20